Loading clinical trials...
Loading clinical trials...
Oncogenic Role of Engrailed (EN)-2 in Epithelial Ovarian Neoplasms.
Conditions
Interventions
Immunohistochemical staining of normal and neoplastic ovarian tissues by anti human Engrailed-2 antibody.
Locations
1
Egypt
Sohag faculty of medicine
Sohag, Egypt
Start Date
January 1, 2015
Primary Completion Date
December 31, 2021
Completion Date
June 1, 2022
Last Updated
September 27, 2022
NCT07213804
NCT06051695
NCT06885697
NCT07035587
NCT01789229
NCT02869568
Lead Sponsor
Sohag University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions